Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RXRX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
RXRX
Recursion Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RXRX
Recursion Pharmaceuticals, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RXRX, solid
AMGN, dashed
RXRX
Recursion Pharmaceuticals, Inc.
Change
4.03
· pre 4.05
Mkt cap
$2.2B
Revenue
$8M
Q2 FY26
Revenue
$75M
FY25
AMGN
Amgen Inc
Change
466.31
· pre 465.85
Pre-market
Sep 2 '83
Mkt cap
$251.9B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Sep 2 '83
RXRX
Recursion Pharmaceuticals, Inc.
vs
AMGN
Amgen Inc
4.03
pre 4.05
Price
466.31
pre 465.85
$2.2B
Mkt cap
$251.9B
Q2 FY26
$8M
Revenue
$10.1B
Q2 FY26
FY25
$75M
Revenue
$36.8B
FY25
Change
Change
RXRX
4.03
vs
AMGN
466.31
Pre-market
Sep 2 '83